WT1/EGR1-mediated control of STIM1 expression and function in cancer cells

Frontiers in Bioscience

Volumn 16, Issue 7, 2011, Pages 2402-2415

  Ritchie, Michael F ^a   Zhou, Yandong ^a   Soboloff, Jonathan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Cancer; EGR1; Review; STIM1; WT1

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN BCL 2; STIM1 PROTEIN, HUMAN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TUMOR PROTEIN; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; BIOLOGICAL MODEL; BRAIN TUMOR; BREAST TUMOR; CALCIUM SIGNALING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HUMAN; MALE; METABOLISM; NEOPLASM; NEPHROBLASTOMA; ONCOGENE; OVARY TUMOR; PROSTATE TUMOR; REVIEW; TUMOR SUPPRESSOR GENE;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CALCIUM SIGNALING; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; GLIOBLASTOMA; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS; ONCOGENES; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSIENT RECEPTOR POTENTIAL CHANNELS; WILMS TUMOR; WT1 PROTEINS;

EID: 79959552132     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3862     Document Type: Article

References (153)

1. A. L. Boynton, J. F. Whitfield, R. J. Isaacs and H. J. Morton: Control of 3T3 cell proliferation by calcium. In vitro, 10, 12-7 (1974)
2. J. F. Whitfield, A. L. Boynton, J. P. MacManus, M. Sikorska and B. K. Tsang: The regulation of cell proliferation by calcium and cyclic AMP. Mol Cell Biochem, 27(3), 155-79 (1979) (Pubitemid 10218207)
3. M. J. Berridge and R. F. Irvine: Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 312(5992), 315-21 (1984) (Pubitemid 15209307)
4. K. Bridges, R. Levenson, D. Housman and L. Cantley: Calcium regulates the commitment of murine erythroleukemia cells to terminal erythroid differentiation. J Cell Biol, 90(2), 542-4 (1981)
5. J. Holliday, R. J. Adams, T. J. Sejnowski and N. C. Spitzer: Calcium-induced release of calcium regulates differentiation of cultured spinal neurons. Neuron, 7(5), 787-96 (1991)
6. S. Orrenius, B. Zhivotovsky and P. Nicotera: Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol, 4(7), 552-65 (2003) (Pubitemid 36773407)
7. A. L. Boynton and J. F. Whitfield: Different calcium requirements for proliferation of conditionally and unconditionally tumorigenic mouse cells. Proc Natl Acad Sci U S A, 73(5), 1651-4 (1976)
8. A. L. Boynton and J. F. Whitfield: Calcium requirements for the proliferation of cells infected with a temperature sensitive mutant of Rous sarcoma virus. Cancer Res, 38(5), 1237-40 (1978) (Pubitemid 8323318)
9. J. F. Whitfield: Calcium signals and cancer. Crit Rev Oncog, 3(1-2), 55-90 (1992)
10. J. M. Adams and S. Cory: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene, 26(9), 1324-37 (2007) (Pubitemid 46328466)
11. A. Frenzel, F. Grespi, W. Chmelewskij and A. Villunger: Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis, 14(4), 584-96 (2009)
12. E. Lomonosova and G. Chinnadurai: BH3-only proteins in apoptosis and beyond: an overview. Oncogene, 27 Suppl 1, S2-19 (2008)
13. 2+ signaling. J Biol Chem, 285(18), 13678-84 (2010)
14. C. Li, X. Wang, H. Vais, C. B. Thompson, J. K. Foskett and C. White: Apoptosis regulation by Bcl-x(L) modulation of mammalian inositol 1,4,5-trisphosphate receptor channel isoform gating. Proc Natl Acad Sci U S A, 104(30), 12565-70 (2007) (Pubitemid 47206178)
15. C. White, C. Li, J. Yang, N. B. Petrenko, M. Madesh, C. B. Thompson and J. K. Foskett: The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat Cell Biol, 7(10), 1021-8 (2005) (Pubitemid 41486277)
16. P. Pinton, D. Ferrari, P. Magalhaes, K. Schulze-Osthoff, F. Di Virgilio, T. Pozzan and R. Rizzuto: Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J Cell Biol, 148(5), 857-62 (2000)
17. 2+ concentration within the endoplasmic reticulum. Proc Natl Acad Sci U S A, 97(11), 5723-8 (2000) (Pubitemid 30367465)
18. Y. P. Rong, G. Bultynck, A. S. Aromolaran, F. Zhong, J. B. Parys, H. De Smedt, G. A. Mignery, H. L. Roderick, M. D. Bootman and C. W. Distelhorst: The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci U S A, 106(34), 14397-402 (2009)
19. Y. P. Rong, A. S. Aromolaran, G. Bultynck, F. Zhong, X. Li, K. McColl, S. Matsuyama, S. Herlitze, H. L. Roderick, M. D. Bootman, G. A. Mignery, J. B. Parys, H. De Smedt and C. W. Distelhorst: Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol Cell, 31(2), 255-65 (2008) (Pubitemid 352001398)
20. S. A. Oakes, L. Scorrano, J. T. Opferman, M. C. Bassik, M. Nishino, T. Pozzan and S. J. Korsmeyer: Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci U S A, 102(1), 105-10 (2005) (Pubitemid 40094436)
21. K. Venkatachalam and C. Montell: TRP channels. Annu Rev Biochem, 76, 387-417 (2007)
22. L. M. Duncan, J. Deeds, J. Hunter, J. Shao, L. M. Holmgren, E. A. Woolf, R. I. Tepper and A. W. Shyjan: Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res, 58(7), 1515-20 (1998) (Pubitemid 28193617)
23. L. Tsavaler, M. H. Shapero, S. Morkowski and R. Laus: Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res, 61(9), 3760-9 (2001) (Pubitemid 32694990)
24. J. B. Peng, L. Zhuang, U. V. Berger, R. M. Adam, B. J. Williams, E. M. Brown, M. A. Hediger and M. R. Freeman: CaT1 expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun, 282(3), 729-34 (2001) (Pubitemid 32924618)
25. V. Lehen'kyi, M. Flourakis, R. Skryma and N. Prevarskaya: TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene, 26(52), 7380-5 (2007) (Pubitemid 350115979)
26. C. El Boustany, G. Bidaux, A. Enfissi, P. Delcourt, N. Prevarskaya and T. Capiod: Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology, 47(6), 2068-77 (2008) (Pubitemid 351945573)
27. J. W. Putney, Jr.: A model for receptor-regulated calcium entry. Cell Calcium, 7(1), 1-12 (1986) (Pubitemid 16130733)
28. 2+ influx. Curr Biol, 15(13), 1235-41 (2005) (Pubitemid 40950523)
29. 2+ channel function. J Cell Biol, 169(3), 435-45 (2005) (Pubitemid 40686694)
30. S. Feske, Y. Gwack, M. Prakriya, S. Srikanth, S. H. Puppel, B. Tanasa, P. G. Hogan, R. S. Lewis, M. Daly and A. Rao: A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature, 441(7090), 179-85 (2006)
31. 2+ entry. Science, 312(5777), 1220-3 (2006) (Pubitemid 43801149)
32. S. L. Zhang, A. V. Yeromin, X. H. Zhang, Y. Yu, O. Safrina, A. Penna, J. Roos, K. A. Stauderman and M. D. Cahalan: Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci U S A, 103(24), 9357-62 (2006) (Pubitemid 43902581)
33. T. Hewavitharana, X. Deng, J. Soboloff and D. L. Gill: Role of STIM and Orai proteins in the store-operated calcium signaling pathway. Cell Calcium, 42(2), 173-82 (2007) (Pubitemid 47029604)
34. 2+ signaling in T cells. Trends Mol Med, 13(3), 103-7 (2007) (Pubitemid 46341959)
35. J. Soboloff, M. A. Spassova, X. D. Tang, T. Hewavitharana, W. Xu and D. L. Gill: Orai1 and STIM Reconstitute Store-operated Calcium Channel Function. J Biol Chem, 281(30), 20661-5 (2006) (Pubitemid 44115407)
36. S. Feske: Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol, 7(9), 690-702 (2007) (Pubitemid 47327393)
37. P. G. Hogan and A. Rao: Dissecting ICRAC, a storeoperated calcium current. Trends Biochem Sci, 32(5), 235-45 (2007) (Pubitemid 46694334)
38. X. Deng, Y. Wang, Y. Zhou, J. Soboloff and D. L. Gill: STIM and Orai: dynamic intermembrane coupling to control cellular calcium signals. J Biol Chem, 284(34), 22501-5 (2009)
39. R. T. Williams, S. S. Manji, N. J. Parker, M. S. Hancock, L. Van Stekelenburg, J. P. Eid, P. V. Senior, J. S. Kazenwadel, T. Shandala, R. Saint, P. J. Smith and M. A. Dziadek: Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem J, 357(Pt 3), 673-85 (2001) (Pubitemid 32735148)
40. P. B. Stathopulos, L. Zheng, G. Y. Li, M. J. Plevin and M. Ikura: Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell, 135(1), 110-22 (2008)
41. 2+ entry. J Biol Chem, 281(47), 35855-62 (2006) (Pubitemid 46041317)
42. P. B. Stathopulos, L. Zheng and M. Ikura: Stromal Interaction Molecule (STIM) 1 and STIM2 Calcium Sensing Regions Exhibit Distinct Unfolding and Oligomerization Kinetics. J Biol Chem, 284(2), 728-32 (2009)
43. T. Hewavitharana, X. Deng, Y. Wang, M. F. Ritchie, G. V. Girish, J. Soboloff and D. L. Gill: Location and function of STIM1 in the activation of Ca2+ entry signals. J Biol Chem, 283(38), 26252-62 (2008)
44. R. M. Luik, B. Wang, M. Prakriya, M. M. Wu and R. S. Lewis: Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation. Nature, 454(7203), 538-42 (2008)
45. 2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. J Cell Biol, 174(6), 803-13 (2006) (Pubitemid 44373730)
46. 2+ entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J Cell Biol, 174(6), 815-25 (2006) (Pubitemid 44373731)
47. Y. Wang, X. Deng, Y. Zhou, E. Hendron, S. Mancarella, M. F. Ritchie, X. D. Tang, Y. Baba, T. Kurosaki, Y. Mori, J. Soboloff and D. L. Gill: STIM protein coupling in the activation of Orai channels. Proc Natl Acad Sci U S A, 106(18), 7391-6 (2009)
48. M. Muik, M. Fahrner, I. Derler, R. Schindl, J. Bergsmann, I. Frischauf, K. Groschner and C. Romanin: A Cytosolic Homomerization and a Modulatory Domain within STIM1 C Terminus Determine Coupling to ORAI1 Channels. J Biol Chem, 284(13), 8421-6 (2009)
49. C. Y. Park, P. J. Hoover, F. M. Mullins, P. Bachhawat, E. D. Covington, S. Raunser, T. Walz, K. C. Garcia, R. E. Dolmetsch and R. S. Lewis: STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell, 136(5), 876-90 (2009)
50. J. P. Yuan, W. Zeng, M. R. Dorwart, Y. J. Choi, P. F. Worley and S. Muallem: SOAR and the polybasic STIM1 domains gate and regulate Orai channels. Nat Cell Biol, 11(3), 337-43 (2009)
51. J. C. Mercer, W. I. Dehaven, J. T. Smyth, B. Wedel, R. R. Boyles, G. S. Bird and J. W. Putney, Jr.: Large storeoperated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. J Biol Chem, 281(34), 24979-90 (2006) (Pubitemid 44274268)
52. C. Peinelt, M. Vig, D. L. Koomoa, A. Beck, M. J. Nadler, M. Koblan-Huberson, A. Lis, A. Fleig, R. Penner and J. P. Kinet: Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol, 8(7), 771-3 (2006)
53. 2+ levels. Cell, 131(7), 1327-39 (2007) (Pubitemid 350297421)
54. S. Parvez, A. Beck, C. Peinelt, J. Soboloff, A. Lis, M. Monteilh-Zoller, D. L. Gill, A. Fleig and R. Penner: STIM2 protein mediates distinct store-dependent and storeindependent modes of CRAC channel activation. Faseb J, 22(3), 752-61 (2008) (Pubitemid 351348128)
55. J. Soboloff, M. A. Spassova, T. Hewavitharana, L. P. He, W. Xu, L. S. Johnstone, M. A. Dziadek and D. L. Gill: STIM2 Is an Inhibitor of STIM1-Mediated Store-Operated Ca(2+) Entry. Curr Biol, 16(14), 1465-70 (2006) (Pubitemid 44088459)
56. Y. Zhou, S. Mancarella, Y. Wang, C. Yue, M. Ritchie, D. L. Gill and J. Soboloff: The Short N-terminal Domains of STIM1 and STIM2 Control the Activation Kinetics of Orai1 Channels. J Biol Chem, 284(29), 19164-8 (2009)
57. W. I. DeHaven, J. T. Smyth, R. R. Boyles and J. W. Putney, Jr.: Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium channels. J Biol Chem, 282(24), 17548-56 (2007) (Pubitemid 47100303)
58. A. Lis, C. Peinelt, A. Beck, S. Parvez, M. Monteilh-Zoller, A. Fleig and R. Penner: CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct functional properties. Curr Biol, 17(9), 794-800 (2007) (Pubitemid 46635119)
59. M. F. Ritchie, C. Yue, Y. Zhou, P. J. Houghton and J. Soboloff: Wilms Tumor Suppressor 1 (WT1) and Early Growth Response 1 (EGR1) Are Regulators of STIM1 Expression. J Biol Chem, 285(14), 10591-6 (2010)
60. A. M. Beckmann, I. Matsumoto and P. A. Wilce: AP-1 and Egr DNA-binding activities are increased in rat brain during ethanol withdrawal. J Neurochem, 69(1), 306-14 (1997) (Pubitemid 27274186)
61. A. Gashler and V. P. Sukhatme: Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol, 50, 191-224 (1995)
62. C. Wang, S. Dostanic, N. Servant and L. E. Chalifour: Egr-1 negatively regulates expression of the sodiumcalcium exchanger-1 in cardiomyocytes in vitro and in vivo. Cardiovasc Res, 65(1), 187-94 (2005) (Pubitemid 40038491)
63. A. Kasneci, N. M. Kemeny-Suss, S. V. Komarova and L. E. Chalifour: Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells. Cardiovasc Res, 81(4), 695-702 (2009)
64. M. Brady, M. U. Koban, K. A. Dellow, M. Yacoub, K. R. Boheler and S. J. Fuller: Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes. Cardiovasc Res, 60(2), 347-54 (2003) (Pubitemid 37412368)
65. S. Hara, M. Arai, K. Tomaru, H. Doi, N. Koitabashi, T. Iso, A. Watanabe, T. Tanaka, T. Maeno, T. Suga, T. Yokoyama and M. Kurabayashi: Prostaglandin F2alpha inhibits SERCA2 gene transcription through an induction of Egr-1 in cultured neonatal rat cardiac myocytes. Int Heart J, 49(3), 329-42 (2008)
66. M. Arai, A. Yoguchi, T. Takizawa, T. Yokoyama, T. Kanda, M. Kurabayashi and R. Nagai: Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription. Circ Res, 86(1), 8-14 (2000) (Pubitemid 30044162)
67. Y. Zhou, M. F. Ritchie, C. Yue, M. Madesh and J. Soboloff: Targeting Store-operated Ca2+ Entry to Induce Cell Death depends on WT1-Regulated SERCA2 expression. Cell Death Differ, in revision (2010)
68. V. Scharnhorst, A. L. Menke, J. Attema, J. K. Haneveld, N. Riteco, G. J. van Steenbrugge, A. J. van der Eb and A. G. Jochemsen: EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene, 19(6), 791-800 (2000) (Pubitemid 30107710)
69. S. K. Bae, M. H. Bae, M. Y. Ahn, M. J. Son, Y. M. Lee, M. K. Bae, O. H. Lee, B. C. Park and K. W. Kim: Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res, 59(23), 5989-94 (1999) (Pubitemid 30004962)
70. T. B. Hamilton, F. Borel and P. J. Romaniuk: Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1. Biochemistry, 37(7), 2051-8 (1998) (Pubitemid 28099829)
71. A. A. Morrison, R. L. Viney and M. R. Ladomery: The post-transcriptional roles of WT1, a multifunctional zincfinger protein. Biochim Biophys Acta, 1785(1), 55-62 (2008) (Pubitemid 350192082)
72. E. Nurmemmedov, R. K. Yengo, H. Uysal, R. Karlsson and M. M. Thunnissen: New insights into DNA-binding behavior of Wilms tumor protein (WT1)-a dual study. Biophys Chem, 145(2-3), 116-25 (2009)
73. D. J. Richard, V. Schumacher, B. Royer-Pokora and S. G. Roberts: Par4 is a coactivator for a splice isoformspecific transcriptional activation domain in WT1. Genes Dev, 15(3), 328-39 (2001) (Pubitemid 32155148)
74. J. D. Gibbs, D. A. Liebermann and B. Hoffman: Leukemia suppressor function of Egr-1 is dependent on transforming oncogene. Leukemia, 22(10), 1909-16 (2008)
75. K. L. Redmond, N. T. Crawford, H. Farmer, Z. C. D'Costa, G. J. O'Brien, N. E. Buckley, R. D. Kennedy, P. G. Johnston, D. P. Harkin and P. B. Mullan: T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells. Oncogene, 29(22), 3252-62 (2010)
76. S. A. Abdulkadir, Z. Qu, E. Garabedian, S. K. Song, T. J. Peters, J. Svaren, J. M. Carbone, C. K. Naughton, W. J. Catalona, J. J. Ackerman, J. I. Gordon, P. A. Humphrey and J. Milbrandt: Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med, 7(1), 101-7 (2001) (Pubitemid 32095648)
77. M. N. Rivera and D. A. Haber: Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer, 5(9), 699-712 (2005) (Pubitemid 41486363)
78. C. Owen, J. Fitzgibbon and P. Paschka: The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia. Hematol Oncol, 28(1), 13-9 (2010)
79. L. Yang, Y. Han, F. Suarez Saiz and M. D. Minden: A tumor suppressor and oncogene: the WT1 story. Leukemia, 21(5), 868-76 (2007) (Pubitemid 46672061)
80. J. L. Gregg, K. E. Brown, E. M. Mintz, H. Piontkivska and G. C. Fraizer: Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection. BMC Cancer, 10, 165 (2010)
81. V. Baron, E. D. Adamson, A. Calogero, G. Ragona and D. Mercola: The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther, 13(2), 115-24 (2006) (Pubitemid 43113412)
82. P. Zapata-Benavides, M. Tuna, G. Lopez-Berestein and A. M. Tari: Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun, 295(4), 784-90 (2002)
83. G. B. Silberstein, K. Van Horn, P. Strickland, C. T. Roberts, Jr. and C. W. Daniel: Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci U S A, 94(15), 8132-7 (1997) (Pubitemid 27343789)
84. Y. Miyoshi, A. Ando, C. Egawa, T. Taguchi, Y. Tamaki, H. Tamaki, H. Sugiyama and S. Noguchi: High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res, 8(5), 1167-71 (2002) (Pubitemid 34517654)
85. K. Kaufmann and G. Thiel: Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells. J Neurol Sci, 189(1-2), 83-91 (2001) (Pubitemid 32776653)
86. M. Takahashi, X. J. Yang, T. T. Lavery, K. A. Furge, B. O. Williams, M. Tretiakova, A. Montag, N. J. Vogelzang, G. G. Re, A. J. Garvin, S. Soderhall, S. Kagawa, D. Hazel- Martin, A. Nordenskjold and B. T. Teh: Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res, 62(22), 6598-605 (2002) (Pubitemid 35364126)
87. A. J. Garvin, G. G. Re, B. I. Tarnowski, D. J. Hazen- Martin and D. A. Sens: The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney. Am J Pathol, 142(2), 375-80 (1993) (Pubitemid 23057449)
88. S. Sabbioni, G. Barbanti-Brodano, C. M. Croce and M. Negrini: GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development. Cancer Res, 57(20), 4493-7 (1997) (Pubitemid 27441051)
89. S. Sabbioni, A. Veronese, M. Trubia, R. Taramelli, G. Barbanti-Brodano, C. M. Croce and M. Negrini: Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD. Cytogenet Cell Genet, 86(3-4), 214-8 (1999)
90. P. J. Houghton, C. L. Morton, C. Tucker, D. Payne, E. Favours, C. Cole, R. Gorlick, E. A. Kolb, W. Zhang, R. Lock, H. Carol, M. Tajbakhsh, C. P. Reynolds, J. M. Maris, J. Courtright, S. T. Keir, H. S. Friedman, C. Stopford, J. Zeidner, J. Wu, T. Liu, C. A. Billups, J. Khan, S. Ansher, J. Zhang and M. A. Smith: The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer, 49(7), 928-40 (2007) (Pubitemid 350022448)
91. R. Natrajan, S. E. Little, J. S. Reis-Filho, L. Hing, B. Messahel, P. E. Grundy, J. S. Dome, T. Schneider, G. M. Vujanic, K. Pritchard-Jones and C. Jones: Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors. Clin Cancer Res, 12(24), 7284-93 (2006) (Pubitemid 46095400)
92. K. Pritchard-Jones and J. Pritchard: Success of clinical trials in childhood Wilms' tumour around the world. Lancet, 364(9444), 1468-70 (2004) (Pubitemid 39410404)
93. S. Wittmann, C. Wunder, B. Zirn, R. Furtwangler, J. Wegert, N. Graf and M. Gessler: New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. Genes Chromosomes Cancer, 47(5), 386-95 (2008) (Pubitemid 351451793)
94. T. F. Zhang, S. Q. Yu, L. S. Guan and Z. Y. Wang: Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of betacatenin. Anticancer Res, 23(5A), 3575-84 (2003)
95. N. Reizner, S. Maor, R. Sarfstein, S. Abramovitch, W. V. Welshons, E. M. Curran, A. V. Lee and H. Werner: The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. J Mol Endocrinol, 35(1), 135-44 (2005) (Pubitemid 41167631)
96. R. K. Motiani, I. F. Abdullaev and M. Trebak: A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J Biol Chem, 285(25), 19173-83 (2010)
97. D. M. Loeb, E. Evron, C. B. Patel, P. M. Sharma, B. Niranjan, L. Buluwela, S. A. Weitzman, D. Korz and S. Sukumar: Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res, 61(3), 921-5 (2001) (Pubitemid 32174404)
98. K. Ronski, M. Sanders, J. A. Burleson, V. Moyo, P. Benn and M. Fang: Early growth response gene 1 (EGR1) is deleted in estrogen receptor-negative human breast carcinoma. Cancer, 104(5), 925-30 (2005) (Pubitemid 41170218)
99. S. Yang, J. J. Zhang and X. Y. Huang: Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell, 15(2), 124-34 (2009)
100. R. B. Walter, F. R. Appelbaum, M. S. Tallman, N. S. Weiss, R. A. Larson and E. H. Estey: Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm. Blood (2010)
101. H. Q. Nguyen, B. Hoffman-Liebermann and D. A. Liebermann: The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell, 72(2), 197-209 (1993) (Pubitemid 23044935)
102. M. Shafarenko, D. A. Liebermann and B. Hoffman: Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation. Blood, 106(3), 871-8 (2005) (Pubitemid 41076426)
103. J. Soboloff, Y. Zhang, M. Minden and S. A. Berger: Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging. Exp Hematol, 30(10), 1219-26 (2002)
104. K. Inoue, H. Tamaki, H. Ogawa, Y. Oka, T. Soma, T. Tatekawa, Y. Oji, A. Tsuboi, E. H. Kim, M. Kawakami, T. Akiyama, T. Kishimoto and H. Sugiyama: Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood, 91(8), 2969-76 (1998) (Pubitemid 28227548)
105. 2+ influx mediated by storeoperated channels in HL60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. J Cell Physiol, 172(3), 284-95 (1997) (Pubitemid 27376194)
106. M. Sekiya, M. Adachi, Y. Hinoda, K. Imai and A. Yachi: Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood, 83(7), 1876-82 (1994) (Pubitemid 24107912)
107. Q. Wang, H. Salman, M. Danilenko and G. P. Studzinski: Cooperation between antioxidants and 1,25-dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway. J Cell Physiol, 204(3), 964-74 (2005) (Pubitemid 41099283)
108. G. Vereb, Jr., J. Szollosi, L. Matyus, M. Balazs, W. C. Hyun and B. G. Feuerstein: Depletion of intracellular calcium stores facilitates the influx of extracellular calcium in platelet derived growth factor stimulated A172 glioblastoma cells. Cytometry, 24(1), 64-73 (1996)
109. G. G. Kovacs, A. Zsembery, S. J. Anderson, P. Komlosi, G. Y. Gillespie, P. D. Bell, D. J. Benos and C. M. Fuller: Changes in intracellular Ca2+ and pH in response to thapsigargin in human glioblastoma cells and normal astrocytes. Am J Physiol Cell Physiol, 289(2), C361-71 (2005) (Pubitemid 41008882)
110. S. Chigurupati, R. Venkataraman, D. Barrera, A. Naganathan, M. Madan, L. Paul, J. V. Pattisapu, G. A. Kyriazis, K. Sugaya, S. Bushnev, J. D. Lathia, J. N. Rich and S. L. Chan: Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res, 70(1), 418-27 (2010)
111. X. Ding, Z. He, K. Zhou, J. Cheng, H. Yao, D. Lu, R. Cai, Y. Jin, B. Dong, Y. Xu and Y. Wang: Essential Role of TRPC6 Channels in G2/M Phase Transition and Development of Human Glioma. J Natl Cancer Inst (2010)
112. H. Wu, J. M. Yang, S. Jin, H. Zhang and W. N. Hait: Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res, 66(6), 3015-23 (2006)
113. T. Szado, V. Vanderheyden, J. B. Parys, H. De Smedt, K. Rietdorf, L. Kotelevets, E. Chastre, F. Khan, U. Landegren, O. Soderberg, M. D. Bootman and H. L. Roderick: Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc Natl Acad Sci U S A, 105(7), 2427-32 (2008) (Pubitemid 351520530)
114. A. Yacoub, H. A. Hamed, J. Allegood, C. Mitchell, S. Spiegel, M. S. Lesniak, B. Ogretmen, R. Dash, D. Sarkar, W. C. Broaddus, S. Grant, D. T. Curiel, P. B. Fisher and P. Dent: PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res, 70(3), 1120-9 (2010)
115. C. A. Scrideli, C. G. Carlotti, Jr., O. K. Okamoto, V. S. Andrade, M. A. Cortez, F. J. Motta, A. K. Lucio-Eterovic, L. Neder, S. Rosemberg, S. M. Oba-Shinjo, S. K. Marie and L. G. Tone: Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR. J Neurooncol, 88(3), 281-91 (2008)
116. Y. Ruano, M. Mollejo, T. Ribalta, C. Fiano, F. I. Camacho, E. Gomez, A. R. de Lope, J. L. Hernandez- Moneo, P. Martinez and B. Melendez: Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer, 5, 39 (2006)
117. C. Liu, J. Yao, D. Mercola and E. Adamson: The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251. J Biol Chem, 275(27), 20315-23 (2000) (Pubitemid 30457606)
118. R. P. Huang, C. Liu, Y. Fan, D. Mercola and E. D. Adamson: Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res, 55(21), 5054-62 (1995)
119. M. Mittelbronn, P. Harter, A. Warth, A. Lupescu, K. Schilbach, H. Vollmann, D. Capper, B. Goeppert, K. Frei, H. Bertalanffy, M. Weller, R. Meyermann, F. Lang and P. Simon: EGR-1 is regulated by N-methyl-D- aspartatereceptor stimulation and associated with patient survival in human high grade astrocytomas. Brain Pathol, 19(2), 195-204 (2009)
120. A. J. Clark, J. L. Ware, M. Y. Chen, M. R. Graf, T. E. Van Meter, W. G. Dos Santos, H. L. Fillmore and W. C. Broaddus: Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells. J Neurosurg, 112(1), 18-25 (2010)
121. N. Hashimoto, A. Tsuboi, Y. Chiba, S. Izumoto, Y. Oka, T. Yoshimine and H. Sugiyama: [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors]. Brain Nerve, 61(7), 805-14 (2009)
122. Y. Nakahara, H. Okamoto, T. Mineta and K. Tabuchi: Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas. Brain Tumor Pathol, 21(3), 113-6 (2004) (Pubitemid 40187985)
123. J. Schittenhelm, M. Mittelbronn, T. D. Nguyen, R. Meyermann and R. Beschorner: WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes. Brain Pathol, 18(3), 344-53 (2008) (Pubitemid 351782842)
124. T. Hashiba, S. Izumoto, N. Kagawa, T. Suzuki, N. Hashimoto, M. Maruno and T. Yoshimine: Expression of WT1 protein and correlation with cellular proliferation in glial tumors. Neurol Med Chir (Tokyo), 47(4), 165-70; discussion 170 (2007) (Pubitemid 46663616)
125. 2+ homeostasis of advanced prostate cancer cells. Biochim Biophys Acta, 1793(6), 1105-9 (2009)
126. Y. Gong, L. J. Blok, J. E. Perry, J. K. Lindzey and D. J. Tindall: Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP. Endocrinology, 136(5), 2172-8 (1995)
127. 2+ homeostasis and apoptotic resistance of neuroendocrinedifferentiated prostate cancer cells. Cell Death Differ, 11(3), 321-30 (2004) (Pubitemid 38313141)
128. F. Vanden Abeele, R. Skryma, Y. Shuba, F. Van Coppenolle, C. Slomianny, M. Roudbaraki, B. Mauroy, F. Wuytack and N. Prevarskaya: Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell, 1(2), 169-79 (2002) (Pubitemid 41039163)
129. J. Yu, I. de Belle, H. Liang and E. D. Adamson: Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol Cell, 15(1), 83-94 (2004) (Pubitemid 38850221)
130. S. A. Abdulkadir, J. M. Carbone, C. K. Naughton, P. A. Humphrey, W. J. Catalona and J. Milbrandt: Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol, 32(9), 935-9 (2001) (Pubitemid 32911315)
131. J. Svaren, T. Ehrig, S. A. Abdulkadir, M. U. Ehrengruber, M. A. Watson and J. Milbrandt: EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem, 275(49), 38524-31 (2000) (Pubitemid 32009180)
132. Y. Furuya, P. Lundmo, A. D. Short, D. L. Gill and J. T. Isaacs: The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res, 54(23), 6167-75 (1994)
133. S. B. Christensen, A. Andersen, H. Kromann, M. Treiman, B. Tombal, S. Denmeade and J. T. Isaacs: Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells. Bioorg Med Chem, 7(7), 1273-80 (1999) (Pubitemid 29292369)
134. H. Sohoel, A. M. Jensen, J. V. Moller, P. Nissen, S. R. Denmeade, J. T. Isaacs, C. E. Olsen and S. B. Christensen: Natural products as starting materials for development of second-generation SERCA inhibitors targeted towards prostate cancer cells. Bioorg Med Chem, 14(8), 2810-5 (2006) (Pubitemid 43343668)
135. C. Picard, C. A. McCarl, A. Papolos, S. Khalil, K. Luthy, C. Hivroz, F. LeDeist, F. Rieux-Laucat, G. Rechavi, A. Rao, A. Fischer and S. Feske: STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med, 360(19), 1971-80 (2009)
136. R. T. Greenlee, M. B. Hill-Harmon, T. Murray and M. Thun: Cancer statistics, 2001. CA Cancer J Clin, 51(1), 15-36 (2001) (Pubitemid 32166444)
137. N. Auersperg, A. S. Wong, K. C. Choi, S. K. Kang and P. C. Leung: Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev, 22(2), 255-88 (2001) (Pubitemid 32458162)
138. C. M. Salamanca, S. L. Maines-Bandiera, P. C. Leung, Y. L. Hu and N. Auersperg: Effects of epidermal growth factor/hydrocortisone on the growth and differentiation of human ovarian surface epithelium. J Soc Gynecol Investig, 11(4), 241-51 (2004) (Pubitemid 38561370)
139. P. Hohenstein and N. D. Hastie: The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet, 15 Spec No 2, R196-201 (2006) (Pubitemid 44446794)
140. S. Hosono, X. Luo, D. P. Hyink, L. M. Schnapp, P. D. Wilson, C. R. Burrow, J. C. Reddy, G. F. Atweh and J. D. Licht: WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene, 18(2), 417-27 (1999) (Pubitemid 29060617)
141. L. Saxen and H. Sariola: Early organogenesis of the kidney. Pediatr Nephrol, 1(3), 385-92 (1987) (Pubitemid 18016633)
142. K. Pritchard-Jones, S. Fleming, D. Davidson, W. Bickmore, D. Porteous, C. Gosden, J. Bard, A. Buckler, J. Pelletier, D. Housman and et al.: The candidate Wilms' tumour gene is involved in genitourinary development. Nature, 346(6280), 194-7 (1990)
143. J. A. Kreidberg, H. Sariola, J. M. Loring, M. Maeda, J. Pelletier, D. Housman and R. Jaenisch: WT-1 is required for early kidney development. Cell, 74(4), 679-91 (1993) (Pubitemid 23259748)
144. M. Shimizu, T. Toki, Y. Takagi, I. Konishi and S. Fujii: Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol, 19(2), 158-63 (2000) (Pubitemid 30212153)
145. S. Yamamoto, H. Tsuda, T. Kita, K. Maekawa, K. Fujii, K. Kudoh, K. Furuya, S. Tamai, J. Inazawa and O. Matsubara: Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma. Virchows Arch, 451(1), 27-35 (2007)
146. M. V. Barbolina, B. P. Adley, L. D. Shea and M. S. Stack: Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer, 112(7), 1632-41 (2008) (Pubitemid 351441178)
147. W. Netinatsunthorn, J. Hanprasertpong, C. Dechsukhum, R. Leetanaporn and A. Geater: WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study. BMC Cancer, 6, 90 (2006)
148. B. Hylander, E. Repasky, P. Shrikant, M. Intengan, A. Beck, D. Driscoll, P. Singhal, S. Lele and K. Odunsi: Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol Oncol, 101(1), 12-7 (2006)
149. S. M. Huber, G. S. Braun, S. Segerer, R. W. Veh and M. F. Horster: Metanephrogenic mesenchyme-toepithelium transition induces profound expression changes of ion channels. Am J Physiol Renal Physiol, 279(1), F65-76 (2000) (Pubitemid 30619547)
150. P. J. Cullen and P. J. Lockyer: Integration of calcium and Ras signalling. Nat Rev Mol Cell Biol, 3(5), 339-48 (2002) (Pubitemid 34619268)
151. C. R. Schmidt, M. K. Washington, Y. J. Gi, R. J. Coffey, R. D. Beauchamp and A. S. Pearson: Dysregulation of E-cadherin by oncogenic Ras in intestinal epithelial cells is blocked by inhibiting MAP kinase. Am J Surg, 186(5), 426-30 (2003) (Pubitemid 37352822)
152. G. Christofori and H. Semb: The role of the celladhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci, 24(2), 73-6 (1999) (Pubitemid 29346577)
153. K. Sawada, A. K. Mitra, A. R. Radjabi, V. Bhaskar, E. O. Kistner, M. Tretiakova, S. Jagadeeswaran, A. Montag, A. Becker, H. A. Kenny, M. E. Peter, V. Ramakrishnan, S. D. Yamada and E. Lengyel: Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res, 68(7), 2329-39 (2008) (Pubitemid 351521807)